Approval · Notice of Compliance 32799 · 2024
WYOST: Notice of Compliance 32799
Issued March 1, 2024
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 32799
- Date
- March 1, 2024
- Company
- Sandoz Canada Inc.Saint-Hubert, Quebec, Canada
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Canadian reference product
- XGEVA
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| WYOST | 02545764 | Marketed |
Medicinal ingredients
- DENOSUMAB 120 MG per 1.7ML